Across American and European dance floors, clubgoers are falling in love with 3-MMC, a synthetic stimulant described as coke without the irritation. It offers a softer comedown than Ecstasy, less fentanyl risk, is cheaper and longer-lasting than cocaine, and boosts libido, making it popular with chemsex enthusiasts for marathon-style parties lasting 12-24 hours. Users feel better, with a little pep in your step, and can stay focused during client meetings, as a product manager noted.

The drug traces to Dr. Zee, an Israeli-born chemist now in Vancouver, Canada, dubbed the godfather of legal highs. He built an algorithm to design hundreds of psychoactives, testing them on himself before release. Inspired by khat, he created 3-MMC, a cousin of mephedrone. Its supply chain runs through industrial labs in China and India, keeping it available despite EU and US bans in 2022 and 2023.

Therapists and pharma firms view 3-MMC as a psychotherapy and PT SD tool; Definium Therapeutics and Period Pill are testing it for pain relief and mood uplift in phase-1 trials. Yet it carries addictive risk, shown by users with sinus damage and nose scabs. Stable supply chains suggest its rise is likely unstoppable, echoing MDMA’s post-ban boom.